Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
Completed
National Cancer Institute (NCI)
Phase 2
1997-08-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with cisplatin
and vinorelbine in treating patients with refractory or recurrent squamous cell cervical
cancer that has not responded to local therapy.
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
Completed
Gynecologic Oncology Group
Phase 2
1997-08-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with cisplatin
and vinorelbine in treating patients with refractory or recurrent squamous cell cervical
cancer that has not responded to local therapy.
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
Completed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1995-02-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known if combination chemotherapy given after surgery
is more effective than surgery alone for non-small cell lung cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy
following surgery with that of surgery alone in treating patients who have stage I, stage II,
or stage IIIA non-small cell lung cancer.
Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
Unknown status
Ottawa Regional Cancer Centre
Phase 1
1995-07-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug is a way to kill more tumor cells.
PURPOSE: Phase I trial to study the effects of hydroxyurea plus combination chemotherapy in
patients with non-small cell lung cancer.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
